Infections in patients with rheumatoid arthritis treated with biologic agents
J Listing, A Strangfeld, S Kary, R Rau… - Arthritis & …, 2005 - Wiley Online Library
Objective To estimate the incidence rates of serious and nonserious infections in patients
with rheumatoid arthritis (RA) who start treatment with a biologic agent, and to compare …
with rheumatoid arthritis (RA) who start treatment with a biologic agent, and to compare …
[HTML][HTML] Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFα inhibitors and rituximab
J Listing, J Kekow, B Manger, GR Burmester… - Annals of the …, 2015 - ard.bmj.com
Objectives To investigate the impact of disease activity, the course of the disease, its
treatment over time, comorbidities and traditional risk factors on survival. Methods Data of …
treatment over time, comorbidities and traditional risk factors on survival. Methods Data of …
Does tumor necrosis factor α inhibition promote or prevent heart failure in patients with rheumatoid arthritis?
J Listing, A Strangfeld, J Kekow… - … : Official Journal of …, 2008 - Wiley Online Library
Objective To determine the hazard risk of developing or worsening heart failure in
rheumatoid arthritis (RA) patients treated with tumor necrosis factor α (TNFα) inhibitors …
rheumatoid arthritis (RA) patients treated with tumor necrosis factor α (TNFα) inhibitors …
Rheumatoid arthritis, a complex multifactorial disease: on the way toward individualized medicine
MO Glocker, R Guthke, J Kekow… - Medicinal research …, 2006 - Wiley Online Library
With the availability of the human genome sequence and those of related species like
chimpanzee, mouse, and rat, data driven research for tackling the molecular grounds of …
chimpanzee, mouse, and rat, data driven research for tackling the molecular grounds of …
[HTML][HTML] Clinical and functional remission: even though biologics are superior to conventional DMARDs overall success rates remain low–results from RABBIT, the …
J Listing, A Strangfeld, R Rau, J Kekow… - Arthritis research & …, 2006 - Springer
We investigated the frequency of remission according to the disease activity score (DAS28)
definition, modified American Rheumatology Association (ARA) criteria, and the frequency of …
definition, modified American Rheumatology Association (ARA) criteria, and the frequency of …
Comparative effects of teriparatide and strontium ranelate on bone biopsies and biochemical markers of bone turnover in postmenopausal women with osteoporosis
We assessed the effects on bone remodeling and histomorphometry after daily
subcutaneous injections of teriparatide (n= 39, 20 μg/d) or oral strontium ranelate (SrR, n …
subcutaneous injections of teriparatide (n= 39, 20 μg/d) or oral strontium ranelate (SrR, n …
Capsule Impedes Adhesion to and Invasion of Epithelial Cells by Klebsiella pneumoniae
H Sahly, R Podschun, TA Oelschlaeger… - Infection and …, 2000 - Am Soc Microbiol
The adhesion of K21a, K26, K36, and K50 capsulated Klebsiella strains to ileocecal (HCT-8)
and bladder (T24) epithelial cell lines was significantly lower than that of their corresponding …
and bladder (T24) epithelial cell lines was significantly lower than that of their corresponding …
Mass spectrometric proteome analyses of synovial fluids and plasmas from patients suffering from rheumatoid arthritis and comparison to reactive arthritis or …
A Sinz, M Bantscheff, S Mikkat, B Ringel… - …, 2002 - Wiley Online Library
Differential proteome analysis is used to study body fluids from patients suffering from
rheumatoid arthritis (RA), reactive arthritis (reaA) or osteoarthritis (OA). Mass spectrometric …
rheumatoid arthritis (RA), reactive arthritis (reaA) or osteoarthritis (OA). Mass spectrometric …
Comparative effectiveness of tumour necrosis factor α inhibitors in combination with either methotrexate or leflunomide
A Strangfeld, F Hierse, J Kekow… - Annals of the …, 2009 - ard.bmj.com
Objective: The objective of this study was to compare the effectiveness of a combination of
tumour necrosis factor α (TNFα) inhibitors with either methotrexate or leflunomide in the …
tumour necrosis factor α (TNFα) inhibitors with either methotrexate or leflunomide in the …
Transforming growth factor beta and noncytopathic mechanisms of immunodeficiency in human immunodeficiency virus infection.
J Kekow, W Wachsman… - Proceedings of the …, 1990 - National Acad Sciences
This study examines the contribution of transforming growth factor beta (TGF beta), one of
the most potent endogenous immunosuppressive factors, to the development of …
the most potent endogenous immunosuppressive factors, to the development of …